01 292BOEHRINGER INGELHEIM
01 510022379*PED
02 110034877*PED
03 610258637*PED
04 310973827*PED
05 311033552*PED
06 611090323*PED
07 611833166*PED
08 612115179*PED
09 1212364700*PED
10 127407955
11 127407955*PED
12 67579449
13 67579449*PED
14 67713938
15 67713938*PED
16 68551957
17 68551957*PED
18 88673927
19 88673927*PED
20 48846695
21 48846695*PED
22 18853156
23 18853156*PED
24 128883805
25 128883805*PED
26 99155705
27 59155705*PED
28 49173859
29 29173859*PED
30 99415016
31 19486526
32 49555001
33 69949998
34 910022379
35 110034877
36 610258637
37 410406172
38 810596120
39 310973827
40 311033552
41 611090323
42 311564886
43 1211833166
44 611911388
45 612115179
46 312178819
47 1212364700
48 59415016*PED
49 19486526*PED
50 29555001*PED
51 49949998*PED
01 24Y
02 268Blank
01 91Y
02 201Blank
01 122025-05-02
02 122025-11-02
03 122025-11-26
04 122026-05-26
05 62027-04-15
06 182027-05-04
07 62027-10-15
08 132027-11-04
09 62028-08-01
10 62029-02-01
11 212029-04-02
12 22029-08-05
13 132029-10-02
14 62029-10-14
15 22030-02-05
16 62030-02-11
17 62030-04-10
18 62030-04-14
19 92030-05-21
20 42030-06-04
21 42030-06-15
22 62030-08-11
23 52030-11-21
24 42030-12-04
25 12031-03-05
26 12031-09-05
27 112032-03-07
28 42033-03-06
29 22033-09-06
30 242034-04-03
31 62034-06-11
32 182034-10-03
33 42034-12-11
34 122037-06-08
35 122037-12-08
Patent Expiration Date : 2027-05-04
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1772
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2031-03-05
US Patent Number : 8853156
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201280
Patent Use Code : U-1642
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2031-03-05
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201280
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2033-03-06
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9555001
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1967
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-06
Patent Expiration Date : 2033-03-06
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9555001
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1968
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-06
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2030-06-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8846695
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2030-06-04
